Saturday, 9 April 2011

Can Malignant Mesothelioma Be Prevented?

The best way to prevent mesotheliomas is to prevent or limit your exposure to asbestos in homes, in public buildings, and at work. People who may be exposed to asbestos at work include miners, factory workers, insulation manufacturers, railroad workers, ship builders, gas mask manufacturers, and construction workers, particularly those involved with insulation. If there is a possibility of on-the-job exposure, such as renovating old buildings, then you should use all protective equipment, work practices, and safety procedures designed for working around asbestos.

If you live in an older home, there may be asbestos-containing insulation or other materials. A knowledgeable expert can check your home to determine if there is any asbestos and if it poses any risk of exposure. This may involve testing the air for asbestos levels. It is often more dangerous to remove the materials containing asbestos than to leave them alone. You may then decide to have the asbestos removed from your home. You should hire a qualified contractor to perform this job, to avoid contaminating your home further or causing any exposure to the workers. You should not attempt to remove asbestos-containing material yourself.

Types of Treatment for Malignant Mesothelioma?

There are different types of treatment for patients with malignant mesothelioma.

Different types of treatments are available for patients with malignant mesothelioma . Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. Before starting treatment, patients may want to think about taking part in a clinical trial. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment.


Clinical trials are taking place in many parts of the country. Information about ongoing clinical trials is available from the NCI Web site. Choosing the most appropriate cancer treatment is a decision that ideally involves the patient, family, and health care team.

Three types of standard treatment are used:

Surgery

The following surgical treatments may be used for malignant mesothelioma:

Wide local excision: Surgery to remove the cancer and some of the healthy tissue around it.
Pleurectomy and decoration: Surgery to remove part of the covering of the lungs and lining of the chest and part of the outside surface of the lungs.
Extraplural pnemonia: Surgery to remove one whole lung and part of the lining of the chest, the diaphragm, and the lining of the sac around the heart.
Pleurodesis: A surgical procedure that uses chemicals or drugs to make a scar in the space between the layers of the pleura. Fluid is first drained from the space using a catheter or chest tube and the chemical or drug is put into the space. The scarring stops the build-up of fluid in the pleural cavity.
Even if the doctor removes all the cancer that can be seen at the time of the surgery, some patients may be given chemotherapy or radiation therapy after surgery to kill any cancer cells that are left. Treatment given after surgery, to increase the chances of a cure, is called adjuvant therapy.

Radiation therapy

Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells. There are two types of radiation therapy. External radiation therapy uses a machine outside the body to send radiation toward the cancer. Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer. The way the radiation therapy is given depends on the type and stage of the cancer being treated.

Chemotherapy

Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the spinal column, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). Combination chemotherapy is the use of more than one anticancer drug. The way the chemotherapy is given depends on the type and stage of the cancer being treated.

Other types of treatment that are being tested in clinical trials include the following:

Biologic therapy is a treatment that uses the patient’s immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body’s natural defenses against cancer. This type of cancer treatment is also called biotherapy or immunotherapy.

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.  

Mesothelioma : Risk Factors

Risk factors are those activities that increase the chance of getting a particular condition or disease. Malignant mesothelioma is a very rare cancer, and the vast majority of cases are associated with exposure to asbestos (either its production or use in various industries). In fact, because asbestos is used so widely in the building and other industries, even in those cases where a history of asbestos exposure is not evident, it is likely that the victim was exposed without his/her knowledge. Other risk factors that are associated with malignant mesothelioma less often include:

Radiation. Cases of malignant mesothelioma have been reported after exposure to radiation, but the association is not very strong. The use of Thorotrast (thorium dioxide), a radioactive substance used for 'contrast' x-ray studies in millions of people between 1930 and 1955, has also been associated with malignant mesothelioma (particularly peritoneal mesothelioma).
Polio vaccine. Between 1955 and 1963, some batches of polio vaccine were contaminated with the Simian Virus 40, which has been detected in certain rare cancers, including malignant mesothelioma.

Erionite. This is a type of zeolite silica stone containing fibrous/wool-like strands that is widely used for house construction in the Cappadocian region of Turkey, where ~1% of the population dies from malignant mesothelioma each year.
Chronic pleural disease. In one study of 35 patients with malignant mesothelioma, 3 had evidence of long-term pleural tuberculosis, but not of asbestos exposure.
Note that smoking tobacco does not appear to increase the risk of developing malignant mesothelioma in those exposed to asbestos. However, smoking does greatly increase the risk of developing bronchogenic lung cancer (i.e. arising in the breathing tubes/airways)

Mesothelioma: Clinical Trials

The purpose of clinical trials: Studies of promising new or experimental treatments in patients are known as clinical trials. A clinical trial is only done when there is some reason to believe that the treatment being studied may be valuable to the patient. Treatments used in clinical trials are often found to have real benefits. Researchers conduct studies of new treatments to answer the following questions:

Is the treatment helpful?
How does this new type of treatment work?
Does it work better than other treatments already available?
What side effects does the treatment cause?
Are the side effects greater or less than the standard treatment?
Do the benefits outweigh the side effects?
In which patients is the treatment most likely to be helpful?
Types of clinical trials: There are 3 phases of clinical trials in which a treatment is studied before it is eligible for approval by the FDA (Food and Drug Administration).

Phase I clinical trials: The purpose of a phase I study is to find the best way to give a new treatment and how much of it can be given safely. The cancer care team watches patients carefully for any harmful side effects. The treatment has been well tested in lab and animal studies, but the side effects in patients are not completely known. Doctors conducting the clinical trial start by giving very low doses of the drug to the first patients and increasing the dose for later groups of patients until side effects appear. Although doctors are hoping to help patients, the main purpose of a phase I study is to test the safety of the drug.

Phase II clinical trials: These studies are designed to see if the drug works. Patients are given the highest dose that doesn’t cause severe side effects (determined from the phase I study) and closely observed for an effect on the cancer. The cancer care team also looks for side effects.

Phase III clinical trials: Phase III studies involve large numbers of patient – often several hundred. One group (the control group) receives the standard (most accepted) treatment. The other group receives the new treatment. All patients in phase III studies are closely watched. The study will be stopped if the side effects of the new treatment are too severe or if one group has had much better results than the others.

If you are in a clinical trial, you will have a team of experts taking care of you and monitoring your progress very carefully. The study is especially designed to pay close attention to you.

However, there are some risks. No one involved in the study knows in advance whether the treatment will work or exactly what side effects will occur. That is what the study is designed to find out. While most side effects disappear in time, some can be permanent or even life threatening. Keep in mind, though, that even standard treatments have side effects. Depending on many factors, you may decide to enroll in a clinical trial.

Deciding to enter a clinical trial: Enrollment in any clinical trial is completely up to you. Your doctors and nurses will explain the study to you in detail and will give you a form to read and sign indicating your desire to take part. This process is known as giving your informed consent. Even after signing the form and after the clinical trial begins, you are free to leave the study at any time, for any reason. Taking part in the study does not prevent you from getting other medical care you may need.

To find out more about clinical trials, ask your cancer care team. Among the questions you should ask are:

Is there a clinical trial for which I would be eligible?
What is the purpose of the study?
What kinds of tests and treatments does the study involve?
What does this treatment do? Has it been used before?
Will I know which treatment I receive?
What is likely to happen in my case with, or without, this new treatment?
What are my other choices and their advantages and disadvantages?
How could the study affect my daily life?
What side effects can I expect from the study? Can the side effects be controlled?
Will I have to be hospitalized? If so, how often and for how long?
Will the study cost me anything? Will any of the treatment be free?
If I am harmed as a result of the research, what treatment would I be entitled to?
What type of long-term follow-up care is part of the study?
Has the treatment been used to treat other types of cancers?
The American Cancer Society offers a clinical trials matching service for patients, their family, and friends. Based on the information you provide about your cancer type, stage, and previous treatments, this service can compile a list of clinical trials that match your medical needs. In finding a center most convenient for you, the service can also take into account where you live and whether you are willing to travel. 

Malignant Mesothelioma: Treatment

If you have mesothelioma, your cancer care team will recommend one or more treatment options for you to consider. This is an important decision and you should take time to think about all of your choices.

In addition to the stage of the cancer, your health and your personal preferences are factors in deciding on a treatment plan. Because mesothelioma is such a rare cancer, it has been difficult for doctors to compare the value of different treatments. Only a few large clinical trials have been reported to date. In addition, most doctors have little or no experience treating this disease. They usually refer patients with this cancer to specialists who treat a large number of mesothelioma patients in large medical centers.

Another problem with treating mesothelioma is that it does not grow as a single tumor mass. It tends to spread along nearby surfaces, nerves, and blood vessels. Because of this it is almost impossible, except in rare situations, to completely get rid of it with surgery, radiation or both.

Because treatment has resulted in modest benefit, you may question the treatment options suggested. It is often a good idea to seek a second opinion. A second opinion can provide more information and help you feel more confident about the treatment plan that you choose. Also, some insurance companies require a second opinion before they will agree to pay for certain treatments
Related Posts Plugin for WordPress, Blogger...

30 Days Popular Posts

All Time Popular Posts

join us

join us
Join us on Facebook

Total Pageviews